Statin induced myopathy

@article{Sathasivam2008StatinIM,
  title={Statin induced myopathy},
  author={S. Sathasivam and B. Lecky},
  journal={BMJ : British Medical Journal},
  year={2008},
  volume={337}
}
Since their introduction for the treatment of hypercholesterolaemia in 1987, the use of statins has grown to over 100 million prescriptions per year.1 About 1.5-3% of statin users in randomised controlled trials and up to 10-13% of participants enrolled in prospective clinical studies develop myalgia.1 2 3 4 As a conservative estimate, at least 1.5 million people per year will experience a muscle related adverse event while taking a statin. In this review we discuss statin induced myopathy and… Expand
Managing statin-induced myopathy.
Statin myopathy: the fly in the ointment for the prevention of cardiovascular disease in the 21st century?
Management of statin myopathy
Myopathy induced by statin-ezetimibe combination: Evaluation of potential risk factors
Rhabdomyolysis following co-prescription of fusidic acid and atorvastatin.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 38 REFERENCES
The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis
A Neuromuscular Approach to Statin-Related Myotoxicity
  • S. Baker, I. Samjoo
  • Medicine
  • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  • 2008
Statin-induced apoptosis and skeletal myopathy.
Statin-Associated Myopathy with Normal Creatine Kinase Levels
Statin safety: a systematic review.
...
1
2
3
4
...